BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33441136)

  • 1. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease.
    Zhou Y; Xu J; Hou Y; Bekris L; Leverenz JB; Pieper AA; Cummings J; Cheng F
    Alzheimers Dement (N Y); 2022; 8(1):e12350. PubMed ID: 36254161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.
    Fang J; Pieper AA; Nussinov R; Lee G; Bekris L; Leverenz JB; Cummings J; Cheng F
    Med Res Rev; 2020 Nov; 40(6):2386-2426. PubMed ID: 32656864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
    Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
    Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
    Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
    Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease.
    Xie L; He B; Varathan P; Nho K; Risacher SL; Saykin AJ; Salama P; Yan J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision pharmacology for Alzheimer's disease.
    Hampel H; Vergallo A; Aguilar LF; Benda N; Broich K; Cuello AC; Cummings J; Dubois B; Federoff HJ; Fiandaca M; Genthon R; Haberkamp M; Karran E; Mapstone M; Perry G; Schneider LS; Welikovitch LA; Woodcock J; Baldacci F; Lista S;
    Pharmacol Res; 2018 Apr; 130():331-365. PubMed ID: 29458203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease.
    Wu Q; Su S; Cai C; Xu L; Fan X; Ke H; Dai Z; Fang S; Zhuo Y; Wang Q; Pan H; Gu Y; Fang J
    Comput Struct Biotechnol J; 2023; 21():1907-1920. PubMed ID: 36936813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
    Talwar P; Sinha J; Grover S; Rawat C; Kushwaha S; Agarwal R; Taneja V; Kukreti R
    Mol Neurobiol; 2016 Sep; 53(7):4833-64. PubMed ID: 26351077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.
    Xu J; Mao C; Hou Y; Luo Y; Binder JL; Zhou Y; Bekris LM; Shin J; Hu M; Wang F; Eng C; Oprea TI; Flanagan ME; Pieper AA; Cummings J; Leverenz JB; Cheng F
    Cell Rep; 2022 Nov; 41(9):111717. PubMed ID: 36450252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer's Disease.
    Singh SK; Kumar A; Singh RB; Ghosh P; Bajad NG
    Curr Top Med Chem; 2022; 22(26):2153-2175. PubMed ID: 36305125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence for drug discovery and development in Alzheimer's disease.
    Qiu Y; Cheng F
    Curr Opin Struct Biol; 2024 Apr; 85():102776. PubMed ID: 38335558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis.
    Peng Y; Yuan M; Xin J; Liu X; Wang J
    Bioinformatics; 2020 Nov; 36(17):4626-4632. PubMed ID: 32516365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer's disease.
    Gupta C; Xu J; Jin T; Khullar S; Liu X; Alatkar S; Cheng F; Wang D
    PLoS Comput Biol; 2022 Jul; 18(7):e1010287. PubMed ID: 35849618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the intercellular communication disruption and key pathways in Alzheimer's disease: an integrative study of single-nucleus transcriptomes and genetic association.
    Liu A; Fernandes BS; Citu C; Zhao Z
    Alzheimers Res Ther; 2024 Jan; 16(1):3. PubMed ID: 38167548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery.
    Yeh SJ; Chung MH; Chen BS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease.
    Zeng Q; Li L; Siu W; Jin Y; Cao M; Li W; Chen J; Cong W; Ma M; Chen K; Wu Z
    Biomed Pharmacother; 2019 Dec; 120():109370. PubMed ID: 31563815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.